secwatch.observer — SEC 8-K summary
======================================

Issuer:     SELECT MEDICAL HOLDINGS CORP (SEM)
CIK:        0001320414
Form:       8-K
Filed at:   2024-02-22T23:59:59+00:00
Accession:  0001104659-24-026568
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Select Medical Q4 net income +63.9%, FY EPS $1.91; issues 2024 guidance
-----------------------------------------------------------------------

- Q4 revenue $1,658.9M (+4.9% YoY); net income $61.8M (+63.9%); EPS $0.36 (+63.6%).
- FY 2023 revenue $6,664.1M (+5.2%); net income $299.7M (+51.4%); adjusted EPS $1.99 (+61.8%).
- Critical illness recovery hospital segment FY Adjusted EBITDA surged 121% to $246.0M.
- Board declared $0.125/share dividend payable March 13, 2024; $1B stock buyback authorized through 2025.
- 2024 outlook: revenue $6.9B–$7.1B, Adjusted EBITDA $830M–$880M, EPS $1.88–$2.18.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1320414/000110465924026568/0001104659-24-026568-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1320414/000110465924026568/tm246929d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-026568

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer